Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.405056188362254e-53,340.9656398104265,41494.472498852825,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",4.861494411733399e-51,0,0,75
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.0334764436398148e-39,129.20325203252034,11598.303357402447,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",1.7879142474968795e-37,0,0,58
3,Oxidative phosphorylation WP623,1.3509292288130133e-22,73.68587570621469,3710.5318056988363,"['NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",1.558071710564342e-20,0,0,34
4,Nonalcoholic fatty liver disease WP4396,1.2064797800735137e-21,12.38657391774161,596.618904848936,"['NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'UQCRFS1', 'CYC1', 'COX8A', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'CYCS', 'BAX']",1.0436050097635894e-19,0,0,48
5,Mitochondrial complex I assembly model OXPHOS system WP4324,4.509724437503228e-18,111.71556550951848,4461.9527120935145,"['NDUFA13', 'NDUFB8', 'NDUFB7', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'NDUFAF3']",3.1207293107522336e-16,0,0,26
6,Mitochondrial CIV Assembly WP4922,1.910971940485113e-12,76.65482796892341,2068.408585176955,"['COX8A', 'COA3', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14']",1.1019938190130817e-10,0,0,18
7,Mitochondrial complex III assembly WP4921,1.4130993531748057e-05,33.694840834248076,376.27500656183196,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.0006984748231406897,0,0,8
8,mRNA Processing WP411,5.208459473325912e-05,7.737151248164464,76.30874774957368,"['SF3B5', 'LSM7', 'SF3A1', 'SNRPD1', 'NCBP2', 'SRSF3', 'SNRPE', 'SNU13', 'HNRNPA1', 'SRSF9', 'LSM2']",0.002252658722213457,0,0,11
9,Eukaryotic Transcription Initiation WP405,5.8636727236472017e-05,16.843029637760704,164.1209956745344,"['GTF2A2', 'TAF13', 'POLR2E', 'POLR3H', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.0022542564026465906,0,0,8
10,Pyrimidine metabolism WP4022,0.00023933697372545095,5.0646085997794925,42.2268734567257,"['POLE4', 'POLE3', 'NME2', 'POLR2E', 'POLR3H', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'NME1', 'POLR2L']",0.008281059290900603,0,0,12
11,Cellular Proteostasis WP4918,0.0002667334986991738,inf,inf,"['VBP1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",0.008389980959083103,0,0,5
12,7q11.23 copy number variation syndrome WP4932,0.0006008635758648512,3.695303867403315,27.408595899042666,"['ATP5PB', 'ATP5MC2', 'HMGA1', 'ATP5MC3', 'UBE2L6', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'EIF4H', 'ATP5PO', 'GAPDH', 'VAMP2']",0.017324899770769876,0,0,14
13,Ciliary landscape WP4352,0.0007101209194608981,3.2205874597901176,23.34950157223277,"['NUDC', 'NDUFA5', 'SSNA1', 'H3F3A', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'LSM4', 'PSMD8', 'MYL6', 'PSMD7', 'EXOSC4', 'RAB14', 'NEFL', 'CALM2']",0.018900141394882365,0,0,16
14,Computational Model of Aerobic Glycolysis WP4629,0.002517413654371502,8.400876232201533,50.27523898180843,"['LDHA', 'TPI1', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.05806834162750264,0,0,6
15,Cori Cycle WP1946,0.002517413654371502,8.400876232201533,50.27523898180843,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.05806834162750264,0,0,6
16,Synaptic Vesicle Pathway WP2267,0.00515107884873876,3.785934065934066,19.94637951972459,"['RAB3A', 'SLC32A1', 'AP2S1', 'PARK7', 'SYP', 'SLC25A4', 'AP2M1', 'VAMP2', 'CPLX3']",0.10129317411811593,0,0,9
17,Proteasome Degradation WP183,0.00515107884873876,3.785934065934066,19.94637951972459,"['PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'PSMC3', 'H2AFZ', 'PSME1', 'PSMB10', 'PSMA7']",0.10129317411811593,0,0,9
18,Photodynamic therapy-induced unfolded protein response WP3613,0.005269587092849962,6.299014238773275,33.04338949154147,"['NARS', 'XBP1', 'DDIT3', 'DNAJB9', 'CALR', 'HSP90B1']",0.10129317411811593,0,0,6
19,Cholesterol Biosynthesis Pathway WP197,0.005860958073950889,16.77377049180328,86.20782383328662,"['IDI1', 'HMGCS1', 'PMVK', 'MSMO1']",0.10673113124142145,0,0,4
20,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.007191127126036963,inf,inf,"['COX8A', 'GSTP1', 'COX5A']",0.12440649928043947,0,0,3
21,Non-small cell lung cancer WP4255,0.00971528335737013,5.037897042716319,23.345892129314187,"['BAD', 'GADD45A', 'CRABP1', 'CYCS', 'BAX', 'HRAS']",0.16007085912619357,0,0,6
22,VEGFA-VEGFR2 Signaling Pathway WP3888,0.010759064198234341,1.6947012401352874,7.680397372173056,"['SET', 'ARPC5L', 'TXN', 'RPL10A', 'RPL7', 'ACTG1', 'LDHA', 'RPL18A', 'TMSB4X', 'AP2S1', 'PGK1', 'RPLP2', 'DNAJB9', 'ELOC', 'ATP6V1E1', 'RPS11', 'CCT7', 'TMSB10', 'HRAS', 'SDF2L1', 'SSR4', 'RPS6', 'RPL13A', 'CYCS', 'RPL27', 'RPL26', 'CALR', 'ALDOA', 'GAPDH', 'SLC25A11', 'PTMA', 'ARF6']",0.16921073693586736,0,0,32
23,Alzheimer's disease WP2059,0.013085890477819597,3.3615806805708015,14.576555704870866,"['PSENEN', 'ATP5MD', 'CDK5', 'BAD', 'CYCS', 'CALM3', 'GAPDH', 'CALM2']",0.19685730892719916,0,0,8
24,Melanoma WP4685,0.014837193244738646,3.6746162280701755,15.472405944346342,"['BAD', 'GADD45A', 'KIT', 'BAX', 'CALM3', 'HRAS', 'CALM2']",0.20614835979895074,0,0,7
25,Fatty acid transporters WP5061,0.014895112702236325,8.384699453551912,35.272100714453735,"['FABP3', 'FABP5', 'FABP6', 'DBI']",0.20614835979895074,0,0,4
26,Translation Factors WP107,0.02206767418801437,3.265472709551657,12.453342071422163,"['EEF1B2', 'EEF1G', 'EIF5', 'EIF6', 'EIF3I', 'EIF4H', 'EIF1']",0.28361864912332335,0,0,7
27,Glycolysis and Gluconeogenesis WP534,0.023976190284898023,2.472659030608943,9.224734240509587,"['LDHA', 'TPI1', 'GOT1', 'MDH2', 'MPC2', 'PGAM1', 'PGK1', 'ALDOA', 'PFKM', 'GAPDH']",0.28361864912332335,0,0,10
28,HIF1A and PPARG regulation of glycolysis WP2456,0.024607853018930537,12.566593886462883,46.5553304146853,"['LDHA', 'TPI1', 'GAPDH']",0.28361864912332335,0,0,3
29,Methionine De Novo and Salvage Pathway WP3580,0.024607853018930537,12.566593886462883,46.5553304146853,"['AHCY', 'ODC1', 'TXN']",0.28361864912332335,0,0,3
30,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.024607853018930537,12.566593886462883,46.5553304146853,"['IDI1', 'HMGCS1', 'PMVK']",0.28361864912332335,0,0,3
31,Ferroptosis WP4313,0.025410919430124343,3.5966202472226567,13.208862274705051,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'VDAC2', 'FTL']",0.28361864912332335,0,0,6
32,Parkinson's disease pathway WP2371,0.02835906318396997,4.193654266958425,14.94118753332743,"['PINK1', 'SYT11', 'CYCS', 'UBE2L6', 'PARK7']",0.3066323706766753,0,0,5
33,Androgen receptor signaling pathway WP138,0.035407556352079005,2.5838047791944607,8.632052585969323,"['SUMO1', 'PRDX1', 'BAG1', 'DSTN', 'STUB1', 'PARK7', 'CALR', 'RAN']",0.36862858519082714,0,0,8
34,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.03728901873317615,inf,inf,"['ELOB', 'ELOC']",0.36862858519082714,0,0,2
35,Mevalonate pathway WP3963,0.03728901873317615,inf,inf,"['HMGCS1', 'PMVK']",0.36862858519082714,0,0,2
36,NO/cGMP/PKG mediated Neuroprotection WP4008,0.04389556849792405,3.4938001458789203,10.921416298979643,"['BAD', 'NPPA', 'NEFL', 'CYCS', 'CALM2']",0.4218851861189367,0,0,5
37,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.050095768313506164,4.19016393442623,12.54459130745224,"['IDI1', 'HMGCS1', 'PMVK', 'MSMO1']",0.45609935124899376,0,0,4
38,Kit receptor signaling pathway WP304,0.050095768313506164,4.19016393442623,12.54459130745224,"['BAD', 'RPS6', 'KIT', 'HRAS']",0.45609935124899376,0,0,4
39,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.05272824869930563,6.281659388646288,18.48443565795495,"['MAP1LC3A', 'ATG101', 'FTL']",0.45609935124899376,0,0,3
40,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.05272824869930563,6.281659388646288,18.48443565795495,"['EIF5', 'EIF3I', 'EIF1']",0.45609935124899376,0,0,3
41,Ras signaling WP4223,0.07353183196266554,1.9081908190819081,4.980448409193371,"['GNG10', 'GNG3', 'RASA4B', 'BAD', 'KIT', 'RAC3', 'CALM3', 'CALM2', 'HRAS', 'ARF6']",0.6173360894945752,0,0,10
42,GABA receptor Signaling WP4159,0.0767209590990368,3.351256830601093,8.604621176651717,"['SLC32A1', 'AP2S1', 'GAD2', 'AP2M1']",0.6173360894945752,0,0,4
43,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.0767209590990368,3.351256830601093,8.604621176651717,"['GOT1', 'MDH2', 'SCO2', 'HMGA1']",0.6173360894945752,0,0,4
44,Cell cycle WP179,0.09053460663929129,1.888021978021978,4.5350724188009,"['CDKN2D', 'ANAPC13', 'PTTG1', 'YWHAQ', 'GADD45A', 'YWHAB', 'SKP1', 'ANAPC11', 'YWHAH']",0.6883626185135432,0,0,9
45,Glycosylation and related congenital defects WP4521,0.09056142520181822,4.186681222707423,10.055265027335478,"['DPM2', 'DPM3', 'MPI']",0.6883626185135432,0,0,3
46,EGF/EGFR signaling pathway WP437,0.09236923445303226,1.973784464389488,4.701478240777487,"['NDUFA13', 'STMN1', 'AP2S1', 'NEDD8', 'HRAS', 'MEF2D', 'AP2M1', 'ARF6']",0.6883626185135432,0,0,8
47,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.09748487950047287,8.368593238822246,19.48257039697181,"['MDH2', 'IDH3B']",0.6883626185135432,0,0,2
48,Hedgehog Signaling Pathway Netpath WP47,0.09748487950047287,8.368593238822246,19.48257039697181,"['SMO', 'SAP18']",0.6883626185135432,0,0,2
49,Peroxiredoxin 2 induced ovarian failure WP4873,0.09748487950047287,8.368593238822246,19.48257039697181,"['STAR', 'BAX']",0.6883626185135432,0,0,2
50,Amyotrophic lateral sclerosis (ALS) WP2447,0.10896224490449069,2.7919854280510017,6.1891444014854615,"['BAD', 'NEFL', 'BAX', 'SOD1']",0.7250180141721881,0,0,4
51,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.10896224490449069,2.7919854280510017,6.1891444014854615,"['ACLY', 'IDI1', 'HMGCS1', 'DBI']",0.7250180141721881,0,0,4
52,Base Excision Repair WP4752,0.10896224490449069,2.7919854280510017,6.1891444014854615,"['POLE4', 'NEIL2', 'APEX1', 'POLE3']",0.7250180141721881,0,0,4
53,Copper homeostasis WP3286,0.11532159601589759,2.327376610746414,5.027204618782281,"['SCO2', 'COX17', 'MT3', 'ATOX1', 'SOD1']",0.7322258294531021,0,0,5
54,DNA Repair Pathways Full Network WP4946,0.11639427924832547,2.095290251916758,4.506491379914839,"['POLE4', 'NEIL2', 'CENPX', 'APEX1', 'POLE3', 'RAD23A']",0.7322258294531021,0,0,6
55,Metabolic reprogramming in colon cancer WP4290,0.11639427924832547,2.095290251916758,4.506491379914839,"['ACLY', 'LDHA', 'MDH2', 'PGAM1', 'PGK1', 'GAPDH']",0.7322258294531021,0,0,6
56,Selenium Micronutrient Network WP15,0.1336794968147252,1.5911818319914932,3.201951365022395,"['SELENOM', 'PRDX5', 'GPX4', 'PRDX1', 'SELENOW', 'TXN', 'SELENOK', 'SEPHS2', 'SELENOH', 'SOD1', 'MSRB1']",0.751048343077589,0,0,11
57,Glycolysis in senescence WP5049,0.13636977671193667,3.1391921397379914,6.254479759778622,"['LDHA', 'PGK1', 'GAPDH']",0.751048343077589,0,0,3
58,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.14614321858826917,2.3925058548009366,4.601191151603383,"['XBP1', 'MAP1LC3A', 'PPP1R11', 'DDIT3']",0.751048343077589,0,0,4
59,IL-3 signaling pathway WP286,0.14614321858826917,2.3925058548009366,4.601191151603383,"['YWHAQ', 'YWHAB', 'BAD', 'HRAS']",0.751048343077589,0,0,4
60,Cytosolic DNA-sensing pathway WP4655,0.1467866971200702,2.0940919037199124,4.018090744384656,"['POLR2E', 'POLR3H', 'POLR3K', 'POLR2K', 'POLR2L']",0.751048343077589,0,0,5
61,Serotonin and anxiety WP3947,0.17036194239957603,4.183206106870229,7.403563799060299,"['POMC', 'CRH']",0.751048343077589,0,0,2
62,Alanine and aspartate metabolism WP106,0.17036194239957603,4.183206106870229,7.403563799060299,"['GOT1', 'GAD2']",0.751048343077589,0,0,2
63,Autophagy WP4923,0.17036194239957603,4.183206106870229,7.403563799060299,"['MAP1LC3B', 'ATG101']",0.751048343077589,0,0,2
64,Trans-sulfuration pathway WP2333,0.17036194239957603,4.183206106870229,7.403563799060299,"['AHCY', 'GOT1']",0.751048343077589,0,0,2
65,Cysteine and methionine catabolism WP4504,0.17036194239957603,4.183206106870229,7.403563799060299,"['AHCY', 'GOT1']",0.751048343077589,0,0,2
66,Dual hijack model of Vif in HIV infection WP3300,0.17036194239957603,4.183206106870229,7.403563799060299,"['ELOB', 'ELOC']",0.751048343077589,0,0,2
67,Gastric acid production WP2596,0.17036194239957603,4.183206106870229,7.403563799060299,"['CCK', 'VIP']",0.751048343077589,0,0,2
68,Lipid Metabolism Pathway WP3965,0.17036194239957603,4.183206106870229,7.403563799060299,"['ACLY', 'PRKAR1A']",0.751048343077589,0,0,2
69,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.17036194239957603,4.183206106870229,7.403563799060299,"['BAD', 'HRAS']",0.751048343077589,0,0,2
70,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.17036194239957603,4.183206106870229,7.403563799060299,"['PTTG1', 'ANAPC11']",0.751048343077589,0,0,2
71,Senescence and Autophagy in Cancer WP615,0.17170874790082855,1.5717032967032967,2.7692713679924132,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3B', 'MAP1LC3A', 'HMGA1', 'ING1', 'HRAS', 'GABARAP', 'SLC39A3']",0.751048343077589,0,0,9
72,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.18142353175903697,1.903222597970957,3.2486506709229137,"['BAD', 'GADD45A', 'RAC3', 'CYCS', 'BAX']",0.751048343077589,0,0,5
73,Modulators of TCR signaling and T cell activation WP5072,0.18142353175903697,1.903222597970957,3.2486506709229137,"['FIBP', 'NDUFB10', 'ELOB', 'RNF7', 'MEF2D']",0.751048343077589,0,0,5
74,IL-18 signaling pathway WP4754,0.1855395329643544,1.3251942286348501,2.2322728533764087,"['NRN1', 'IMP3', 'BAD', 'COX17', 'NDUFC1', 'BPGM', 'RND2', 'PTMS', 'ARL4D', 'NACA', 'TMSB4X', 'STMN1', 'NPPA', 'CYCS', 'BAX', 'RPS11', 'ITM2C', 'ARF6']",0.751048343077589,0,0,18
75,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.18741070317031241,2.092896174863388,3.50445585335539,"['BAD', 'RPS6', 'BAX', 'HRAS']",0.751048343077589,0,0,4
76,Endometrial cancer WP4155,0.18741070317031241,2.092896174863388,3.50445585335539,"['BAD', 'GADD45A', 'BAX', 'HRAS']",0.751048343077589,0,0,4
77,PPAR signaling pathway WP3942,0.18741070317031241,2.092896174863388,3.50445585335539,"['FABP3', 'FABP5', 'FABP6', 'DBI']",0.751048343077589,0,0,4
78,TP53 network WP1742,0.18813419662116806,2.5106986899563317,4.194372626312316,"['SUMO1', 'GADD45A', 'BAX']",0.751048343077589,0,0,3
79,IL-6 signaling pathway WP364,0.18813419662116806,2.5106986899563317,4.194372626312316,"['BAD', 'VIP', 'NR2F6']",0.751048343077589,0,0,3
80,Nanomaterial induced apoptosis WP2507,0.18813419662116806,2.5106986899563317,4.194372626312316,"['ENDOG', 'BAX', 'CYCS']",0.751048343077589,0,0,3
81,Nucleotide Excision Repair WP4753,0.18813419662116806,2.5106986899563317,4.194372626312316,"['POLE4', 'POLE3', 'RAD23A']",0.751048343077589,0,0,3
82,The alternative pathway of fetal androgen synthesis WP4524,0.1931887356471255,inf,inf,['STAR'],0.751048343077589,0,0,1
83,"Cerebral organic acidurias, including diseases WP4519",0.1931887356471255,inf,inf,['MDH2'],0.751048343077589,0,0,1
84,Energy Metabolism WP1541,0.1931887356471255,inf,inf,['MEF2D'],0.751048343077589,0,0,1
85,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.1931887356471255,inf,inf,['MAP1LC3A'],0.751048343077589,0,0,1
86,miRNA Biogenesis WP2338,0.1931887356471255,inf,inf,['RAN'],0.751048343077589,0,0,1
87,Mitochondrial CII Assembly WP4920,0.1931887356471255,inf,inf,['SDHAF1'],0.751048343077589,0,0,1
88,Nanoparticle triggered autophagic cell death WP2509,0.1931887356471255,inf,inf,['MAP1LC3A'],0.751048343077589,0,0,1
89,Nanoparticle-mediated activation of receptor signaling WP2643,0.1931887356471255,inf,inf,['HRAS'],0.751048343077589,0,0,1
90,G Protein Signaling Pathways WP35,0.21870264066166867,1.7441648431801604,2.6512042997192737,"['GNG10', 'GNG3', 'PRKAR1A', 'HRAS', 'CALM2']",0.8407901518770818,0,0,5
91,Pathways in clear cell renal cell carcinoma WP4018,0.223852464760308,1.542763157894737,2.3091586552726877,"['ACLY', 'LDHA', 'TPI1', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.851131349528204,0,0,7
92,Genotoxicity pathway WP4286,0.23182362813072954,1.85986642380085,2.7187126024072077,"['RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1']",0.8694889567290461,0,0,4
93,MET in type 1 papillary renal cell carcinoma WP4205,0.24384081932098983,2.091703056768559,2.9518942822356022,"['BAD', 'RPL11', 'HRAS']",0.8694889567290461,0,0,3
94,p38 MAPK Signaling Pathway WP400,0.24384081932098983,2.091703056768559,2.9518942822356022,"['DDIT3', 'HRAS', 'MEF2D']",0.8694889567290461,0,0,3
95,Myometrial relaxation and contraction pathways WP289,0.24734344664477884,1.3230429988974641,1.8482612162109453,"['RGS4', 'GNG3', 'YWHAQ', 'PRKAR1A', 'YWHAB', 'GSTO1', 'CRH', 'CALM3', 'IGFBP6', 'CALM2', 'ACTG1', 'YWHAH']",0.8694889567290461,0,0,12
96,Tumor suppressor activity of SMARCB1 WP4204,0.24878441247449587,2.7880770628862233,3.878685183150497,"['SMO', 'H3F3A']",0.8694889567290461,0,0,2
97,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.24878441247449587,2.7880770628862233,3.878685183150497,"['BAD', 'BAX']",0.8694889567290461,0,0,2
98,Nucleotide metabolism WP404,0.24878441247449587,2.7880770628862233,3.878685183150497,"['NME2', 'OAZ1']",0.8694889567290461,0,0,2
99,RalA downstream regulated genes WP2290,0.24878441247449587,2.7880770628862233,3.878685183150497,"['RAC3', 'HRAS']",0.8694889567290461,0,0,2
100,Small cell lung cancer WP4658,0.258052010031322,1.6095775122033327,2.1803242419369324,"['GADD45A', 'CYCS', 'BAX', 'CKS1B', 'SKP1']",0.8753528967729158,0,0,5
101,Amino Acid metabolism WP3925,0.258052010031322,1.6095775122033327,2.1803242419369324,"['ACLY', 'LDHA', 'GOT1', 'MDH2', 'ODC1']",0.8753528967729158,0,0,5
102,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.258052010031322,1.6095775122033327,2.1803242419369324,"['POMC', 'BAD', 'NPPA', 'RPS6', 'HRAS']",0.8753528967729158,0,0,5
103,Integrated breast cancer pathway WP1984,0.2756615050413286,1.47709554796727,1.90335814005722,"['GADD45A', 'BAD', 'ODC1', 'BAX', 'PHB', 'FAU']",0.9081546911918528,0,0,6
104,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.2784244387237059,1.6734426229508197,2.1396780817900933,"['APEX1', 'RPS6', 'HRAS', 'MYL12B']",0.9081546911918528,0,0,4
105,Pancreatic adenocarcinoma pathway WP4263,0.2784244387237059,1.6734426229508197,2.1396780817900933,"['BAD', 'GADD45A', 'RAC3', 'BAX']",0.9081546911918528,0,0,4
106,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.2784244387237059,1.6734426229508197,2.1396780817900933,"['BAD', 'STMN1', 'BAX', 'HRAS']",0.9081546911918528,0,0,4
107,16p11.2 proximal deletion syndrome WP4949,0.2988864890847091,1.4942169427946232,1.8045529707320898,"['TMEM219', 'ALDOA', 'SEZ6L2', 'CCT7', 'CDIPT']",0.9081546911918528,0,0,5
108,Aryl Hydrocarbon Receptor Netpath WP2586,0.3016459173624012,1.7924204616344355,2.148218447964807,"['CDC37', 'AIP', 'HRAS']",0.9081546911918528,0,0,3
109,Imatinib and Chronic Myeloid Leukemia WP3640,0.3016459173624012,1.7924204616344355,2.148218447964807,"['GADD45A', 'KIT', 'PIM2']",0.9081546911918528,0,0,3
110,Notch Signaling Pathway Netpath WP61,0.3016459173624012,1.7924204616344355,2.148218447964807,"['PSENEN', 'SKP1', 'DLL3']",0.9081546911918528,0,0,3
111,One-carbon metabolism and related pathways WP3940,0.3016459173624012,1.7924204616344355,2.148218447964807,"['GPX4', 'GAD2', 'SOD1']",0.9081546911918528,0,0,3
112,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.3016459173624012,1.7924204616344355,2.148218447964807,"['STAR', 'CALM3', 'CALM2']",0.9081546911918528,0,0,3
113,Leptin signaling pathway WP2034,0.32629270098117397,1.5209140586189767,1.703363585405413,"['BAD', 'RPS6', 'BAX', 'HRAS']",0.9081546911918528,0,0,4
114,Type 2 papillary renal cell carcinoma WP4241,0.3278958943461338,2.0905125408942205,2.3310450663898137,"['ELOB', 'ELOC']",0.9081546911918528,0,0,2
115,DNA Mismatch Repair WP531,0.3278958943461338,2.0905125408942205,2.3310450663898137,"['POLE4', 'POLE3']",0.9081546911918528,0,0,2
116,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.3278958943461338,2.0905125408942205,2.3310450663898137,"['LDHA', 'RPS6']",0.9081546911918528,0,0,2
117,Histone Modifications WP2369,0.3278958943461338,2.0905125408942205,2.3310450663898137,"['SET', 'H3F3A']",0.9081546911918528,0,0,2
118,Serotonin and anxiety-related events WP3944,0.3490883639552498,4.1797385620915035,4.398883078220608,['CRH'],0.9081546911918528,0,0,1
119,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.3490883639552498,4.1797385620915035,4.398883078220608,['CDC37'],0.9081546911918528,0,0,1
120,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.3490883639552498,4.1797385620915035,4.398883078220608,['DLL3'],0.9081546911918528,0,0,1
121,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.3490883639552498,4.1797385620915035,4.398883078220608,['HMGCS1'],0.9081546911918528,0,0,1
122,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.3490883639552498,4.1797385620915035,4.398883078220608,['ACLY'],0.9081546911918528,0,0,1
123,TCA cycle in senescence WP5050,0.3490883639552498,4.1797385620915035,4.398883078220608,['GOT1'],0.9081546911918528,0,0,1
124,Cell Differentiation - Index WP2029,0.3490883639552498,4.1797385620915035,4.398883078220608,['MEF2D'],0.9081546911918528,0,0,1
125,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.3490883639552498,4.1797385620915035,4.398883078220608,['CCK'],0.9081546911918528,0,0,1
126,Glycerolipids and Glycerophospholipids WP4722,0.3490883639552498,4.1797385620915035,4.398883078220608,['CDIPT'],0.9081546911918528,0,0,1
127,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.3490883639552498,4.1797385620915035,4.398883078220608,['HRAS'],0.9081546911918528,0,0,1
128,Insulin signaling in adipocytes (diabetic condition) WP3635,0.3490883639552498,4.1797385620915035,4.398883078220608,['RPS6'],0.9081546911918528,0,0,1
129,Insulin signaling in adipocytes (normal condition) WP3634,0.3490883639552498,4.1797385620915035,4.398883078220608,['RPS6'],0.9081546911918528,0,0,1
130,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.3490883639552498,4.1797385620915035,4.398883078220608,['AHCY'],0.9081546911918528,0,0,1
131,MTHFR deficiency WP4288,0.3490883639552498,4.1797385620915035,4.398883078220608,['CYCS'],0.9081546911918528,0,0,1
132,NOTCH1 regulation of endothelial cell calcification WP3413,0.3490883639552498,4.1797385620915035,4.398883078220608,['DLL3'],0.9081546911918528,0,0,1
133,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.3490883639552498,4.1797385620915035,4.398883078220608,['MAS1'],0.9081546911918528,0,0,1
134,Aryl Hydrocarbon Receptor Pathway WP2873,0.35995941634370887,1.567958515283843,1.6020835428751035,"['CDC37', 'AIP', 'BAX']",0.9225626522586908,0,0,3
135,CAMKK2  Pathway WP4874,0.35995941634370887,1.567958515283843,1.6020835428751035,"['FIS1', 'MAP1LC3A', 'CALM2']",0.9225626522586908,0,0,3
136,Sleep regulation WP3591,0.37458241197332026,1.393806921675774,1.3686395655411123,"['AHCY', 'STAR', 'CRH', 'HCRTR1']",0.9529817245791824,0,0,4
137,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.40450631653895064,1.6719738276990186,1.5132833256007403,"['RPS6', 'PIM2']",0.9816314978589737,0,0,2
138,Vitamin D-sensitive calcium signaling in depression WP4698,0.40450631653895064,1.6719738276990186,1.5132833256007403,"['GPX4', 'PVALB']",0.9816314978589737,0,0,2
139,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.40450631653895064,1.6719738276990186,1.5132833256007403,"['CD63', 'SOD1']",0.9816314978589737,0,0,2
140,Interleukin-11 Signaling Pathway WP2332,0.40450631653895064,1.6719738276990186,1.5132833256007403,"['RPS6', 'HRAS']",0.9816314978589737,0,0,2
141,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.40450631653895064,1.6719738276990186,1.5132833256007403,"['STAR', 'HRAS']",0.9816314978589737,0,0,2
142,PDGF Pathway WP2526,0.40450631653895064,1.6719738276990186,1.5132833256007403,"['ARFIP2', 'HRAS']",0.9816314978589737,0,0,2
143,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.4237211413916891,1.1301400410311302,0.9704283402284427,"['YWHAQ', 'PRKAR1A', 'YWHAB', 'TAC1', 'ALDOA', 'GAPDH', 'SLC25A4', 'VAMP2', 'HSP90B1', 'YWHAH']",0.9816314978589737,0,0,10
144,Calcium Regulation in the Cardiac Cell WP536,0.4245680201276686,1.1403596403596403,0.9769267750227072,"['RGS4', 'GNG3', 'YWHAQ', 'PRKAR1A', 'YWHAB', 'CALM3', 'CALR', 'CALM2', 'YWHAH']",0.9816314978589737,0,0,9
145,TNF-alpha signaling pathway WP231,0.42554306966257616,1.1944922547332186,1.0205611801481158,"['BAD', 'CDC37', 'BAX', 'TXN', 'HRAS', 'SKP1']",0.9816314978589737,0,0,6
146,Hepatitis B infection WP4666,0.42554306966257616,1.1944922547332186,1.0205611801481158,"['YWHAQ', 'YWHAB', 'BAD', 'CYCS', 'BAX', 'HRAS']",0.9816314978589737,0,0,6
147,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.42554306966257616,1.1944922547332186,1.0205611801481158,"['PSMD8', 'PSMC5', 'PSMD7', 'PSMC3', 'UBE2L6', 'STUB1']",0.9816314978589737,0,0,6
148,Exercise-induced Circadian Regulation WP410,0.4695434945943128,1.1940671350507417,0.9027080009098041,"['IDI1', 'SUMO1', 'GSTP1', 'STBD1']",0.9816314978589737,0,0,4
149,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.47317121187763356,1.253711790393013,0.9381500075782158,"['LDHA', 'PGK1', 'BAX']",0.9816314978589737,0,0,3
150,ACE Inhibitor Pathway WP554,0.4748900279777051,2.0893246187363834,1.5558615880295492,['MAS1'],0.9816314978589737,0,0,1
151,Airway smooth muscle cell contraction WP4962,0.4748900279777051,2.0893246187363834,1.5558615880295492,['CALM2'],0.9816314978589737,0,0,1
152,Splicing factor NOVA regulated synaptic proteins WP4148,0.4748900279777051,2.0893246187363834,1.5558615880295492,['APLP2'],0.9816314978589737,0,0,1
153,Trans-sulfuration and one-carbon metabolism WP2525,0.4748900279777051,2.0893246187363834,1.5558615880295492,['AHCY'],0.9816314978589737,0,0,1
154,Dopamine metabolism WP2436,0.4748900279777051,2.0893246187363834,1.5558615880295492,['SOD1'],0.9816314978589737,0,0,1
155,Fatty acid beta-oxidation WP143,0.4748900279777051,2.0893246187363834,1.5558615880295492,['TPI1'],0.9816314978589737,0,0,1
156,Fatty Acid Biosynthesis WP357,0.4748900279777051,2.0893246187363834,1.5558615880295492,['ACLY'],0.9816314978589737,0,0,1
157,Hippo-Yap signaling pathway WP4537,0.4748900279777051,2.0893246187363834,1.5558615880295492,['YWHAQ'],0.9816314978589737,0,0,1
158,Iron metabolism in placenta WP2007,0.4748900279777051,2.0893246187363834,1.5558615880295492,['FTH1'],0.9816314978589737,0,0,1
159,Overview of nanoparticle effects WP3287,0.4748900279777051,2.0893246187363834,1.5558615880295492,['BAX'],0.9816314978589737,0,0,1
160,Phosphoinositides metabolism WP4971,0.4748900279777051,2.0893246187363834,1.5558615880295492,['PIP4P1'],0.9816314978589737,0,0,1
161,Purine metabolism and related disorders WP4224,0.4748900279777051,2.0893246187363834,1.5558615880295492,['APRT'],0.9816314978589737,0,0,1
162,Purine metabolism WP4792,0.4748900279777051,2.0893246187363834,1.5558615880295492,['APRT'],0.9816314978589737,0,0,1
163,Rett syndrome causing genes WP4312,0.4748900279777051,2.0893246187363834,1.5558615880295492,['IMPDH2'],0.9816314978589737,0,0,1
164,Endothelin Pathways WP2197,0.47663032265984856,1.3929480189022174,1.0321941134795125,"['RIIAD1', 'CALM2']",0.9816314978589737,0,0,2
165,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.47663032265984856,1.3929480189022174,1.0321941134795125,"['BANF1', 'HRAS']",0.9816314978589737,0,0,2
166,G13 Signaling Pathway WP524,0.47663032265984856,1.3929480189022174,1.0321941134795125,"['ARHGDIG', 'CALM2']",0.9816314978589737,0,0,2
167,Galanin receptor pathway WP4970,0.47663032265984856,1.3929480189022174,1.0321941134795125,"['POMC', 'VAMP2']",0.9816314978589737,0,0,2
168,IL-2 signaling pathway WP49,0.47663032265984856,1.3929480189022174,1.0321941134795125,"['RPS6', 'HRAS']",0.9816314978589737,0,0,2
169,Gastrin signaling pathway WP4659,0.5065836483224995,1.099562363238512,0.7477747793504892,"['BAD', 'RPS6', 'KIT', 'HRAS', 'MEF2D']",0.9817794151779391,0,0,5
170,DNA damage response WP707,0.5150520063749146,1.1141712204007286,0.7392385663619045,"['CDK5', 'GADD45A', 'CYCS', 'BAX']",0.9817794151779391,0,0,4
171,miRNA regulation of DNA damage response WP1530,0.5150520063749146,1.1141712204007286,0.7392385663619045,"['CDK5', 'GADD45A', 'CYCS', 'BAX']",0.9817794151779391,0,0,4
172,Regulation of Actin Cytoskeleton WP51,0.5150520063749146,1.1141712204007286,0.7392385663619045,"['TMSB4X', 'BRK1', 'RAC3', 'ACTG1']",0.9817794151779391,0,0,4
173,Urea cycle and associated pathways WP4595,0.5431415690170444,1.1936438697616452,0.7285826436147225,"['GOT1', 'MDH2']",0.9817794151779391,0,0,2
174,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.5431415690170444,1.1936438697616452,0.7285826436147225,"['RAB3A', 'NEFL']",0.9817794151779391,0,0,2
175,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.5431415690170444,1.1936438697616452,0.7285826436147225,"['YWHAQ', 'ACTG1']",0.9817794151779391,0,0,2
176,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.5431415690170444,1.1936438697616452,0.7285826436147225,"['TKFC', 'PIN1']",0.9817794151779391,0,0,2
177,Oxidative Stress WP408,0.5431415690170444,1.1936438697616452,0.7285826436147225,"['TXN2', 'SOD1']",0.9817794151779391,0,0,2
178,Thermogenesis WP4321,0.5762817160923418,1.0442139737991267,0.5755275614098168,"['RPS6', 'HRAS', 'ACTG1']",0.9817794151779391,0,0,3
179,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.5763993128107977,1.3925199709513436,0.7672152934275669,['HRAS'],0.9817794151779391,0,0,1
180,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.5763993128107977,1.3925199709513436,0.7672152934275669,['MEF2D'],0.9817794151779391,0,0,1
181,Sulfation Biotransformation Reaction WP692,0.5763993128107977,1.3925199709513436,0.7672152934275669,['SULT4A1'],0.9817794151779391,0,0,1
182,Biomarkers for urea cycle disorders WP4583,0.5763993128107977,1.3925199709513436,0.7672152934275669,['GOT1'],0.9817794151779391,0,0,1
183,Cell Differentiation - Index expanded WP2023,0.5763993128107977,1.3925199709513436,0.7672152934275669,['MEF2D'],0.9817794151779391,0,0,1
184,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.5763993128107977,1.3925199709513436,0.7672152934275669,['VIP'],0.9817794151779391,0,0,1
185,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.5763993128107977,1.3925199709513436,0.7672152934275669,['H3F3A'],0.9817794151779391,0,0,1
186,Gastric Cancer Network 1 WP2361,0.5763993128107977,1.3925199709513436,0.7672152934275669,['H3F3A'],0.9817794151779391,0,0,1
187,Gastric Cancer Network 2 WP2363,0.5763993128107977,1.3925199709513436,0.7672152934275669,['S100A6'],0.9817794151779391,0,0,1
188,Glycerophospholipid Biosynthetic Pathway WP2533,0.5763993128107977,1.3925199709513436,0.7672152934275669,['CDIPT'],0.9817794151779391,0,0,1
189,Hedgehog Signaling Pathway WP4249,0.5763993128107977,1.3925199709513436,0.7672152934275669,['SMO'],0.9817794151779391,0,0,1
190,Intraflagellar transport proteins binding to dynein WP4532,0.5763993128107977,1.3925199709513436,0.7672152934275669,['DYNLL1'],0.9817794151779391,0,0,1
191,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5763993128107977,1.3925199709513436,0.7672152934275669,['BAX'],0.9817794151779391,0,0,1
192,Nanoparticle triggered regulated necrosis WP2513,0.5763993128107977,1.3925199709513436,0.7672152934275669,['FTL'],0.9817794151779391,0,0,1
193,One-carbon metabolism WP241,0.5763993128107977,1.3925199709513436,0.7672152934275669,['AHCY'],0.9817794151779391,0,0,1
194,PDGFR-beta pathway WP3972,0.5763993128107977,1.3925199709513436,0.7672152934275669,['HRAS'],0.9817794151779391,0,0,1
195,PPAR-alpha pathway WP2878,0.5763993128107977,1.3925199709513436,0.7672152934275669,['DBI'],0.9817794151779391,0,0,1
196,TGF-beta Signaling Pathway WP366,0.5833652937377075,0.994321142023549,0.5358811395233868,"['PARD6A', 'CITED1', 'SUMO1', 'STRAP', 'SKP1']",0.9817794151779391,0,0,5
197,Insulin Signaling WP481,0.5833652937377075,0.994321142023549,0.5358811395233868,"['XBP1', 'HRAS', 'PFKM', 'VAMP2', 'ARF6']",0.9817794151779391,0,0,5
198,Acute viral myocarditis WP4298,0.6000477219267891,0.9825779492124719,0.5018478460580004,"['ENDOG', 'RAC3', 'CYCS', 'BAX']",0.9817794151779391,0,0,4
199,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6000477219267891,0.9825779492124719,0.5018478460580004,"['TMSB4X', 'NEFL', 'PFN2', 'SOD1']",0.9817794151779391,0,0,4
200,AGE/RAGE pathway WP2324,0.603515436965535,1.044165757906216,0.5272866457682233,"['CYCS', 'SOD1']",0.9817794151779391,0,0,2
201,Cardiac Hypertrophic Response WP2795,0.603515436965535,1.044165757906216,0.5272866457682233,"['NPPA', 'CALM2']",0.9817794151779391,0,0,2
202,Cardiac Progenitor Differentiation WP2406,0.603515436965535,1.044165757906216,0.5272866457682233,"['MESP1', 'KIT']",0.9817794151779391,0,0,2
203,Unfolded protein response WP4925,0.603515436965535,1.044165757906216,0.5272866457682233,"['XBP1', 'DDIT3']",0.9817794151779391,0,0,2
204,Common Pathways Underlying Drug Addiction WP2636,0.603515436965535,1.044165757906216,0.5272866457682233,"['CALM2', 'ACTG1']",0.9817794151779391,0,0,2
205,DNA IR-double strand breaks and cellular response via ATM WP3959,0.603515436965535,1.044165757906216,0.5272866457682233,"['CDK5', 'BAX']",0.9817794151779391,0,0,2
206,ErbB signaling pathway WP673,0.603515436965535,1.044165757906216,0.5272866457682233,"['BAD', 'HRAS']",0.9817794151779391,0,0,2
207,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.603515436965535,1.044165757906216,0.5272866457682233,"['H2AFZ', 'H3F3A']",0.9817794151779391,0,0,2
208,Integrated Cancer Pathway WP1971,0.603515436965535,1.044165757906216,0.5272866457682233,"['BAD', 'BAX']",0.9817794151779391,0,0,2
209,Integrin-mediated Cell Adhesion WP185,0.603515436965535,1.044165757906216,0.5272866457682233,"['RAC3', 'HRAS']",0.9817794151779391,0,0,2
210,Adipogenesis WP236,0.6036846648603998,0.9635184093015419,0.48629091637542005,"['GADD45A', 'DDIT3', 'HMGA1', 'NDN', 'MIF', 'MEF2D']",0.9817794151779391,0,0,6
211,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.6532041699828137,0.9073827418894491,0.3864230358959068,"['RAB3A', 'CDK5', 'BAD', 'RPS6', 'HRAS']",0.9817794151779391,0,0,5
212,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6576389486048564,0.9279050042408821,0.38888425291513623,"['CYCS', 'ACTG1']",0.9817794151779391,0,0,2
213,Glycogen Synthesis and Degradation WP500,0.6576389486048564,0.9279050042408821,0.38888425291513623,"['CALM3', 'CALM2']",0.9817794151779391,0,0,2
214,p53 transcriptional gene network WP4963,0.6576389486048564,0.9279050042408821,0.38888425291513623,"['GADD45A', 'BAX']",0.9817794151779391,0,0,2
215,Regulation of Microtubule Cytoskeleton WP2038,0.6576389486048564,0.9279050042408821,0.38888425291513623,"['PARD6A', 'STMN1']",0.9817794151779391,0,0,2
216,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6583029604661326,1.0441176470588236,0.4365351756469044,['HRAS'],0.9817794151779391,0,0,1
217,BDNF-TrkB Signaling WP3676,0.6583029604661326,1.0441176470588236,0.4365351756469044,['HRAS'],0.9817794151779391,0,0,1
218,Cannabinoid receptor signaling WP3869,0.6583029604661326,1.0441176470588236,0.4365351756469044,['PRKAR1A'],0.9817794151779391,0,0,1
219,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.6583029604661326,1.0441176470588236,0.4365351756469044,['STAR'],0.9817794151779391,0,0,1
220,ERK Pathway in Huntington's Disease WP3853,0.6583029604661326,1.0441176470588236,0.4365351756469044,['HRAS'],0.9817794151779391,0,0,1
221,Ethanol effects on histone modifications WP3996,0.6583029604661326,1.0441176470588236,0.4365351756469044,['AHCY'],0.9817794151779391,0,0,1
222,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6583029604661326,1.0441176470588236,0.4365351756469044,['HRAS'],0.9817794151779391,0,0,1
223,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6583029604661326,1.0441176470588236,0.4365351756469044,['RPS6'],0.9817794151779391,0,0,1
224,Genes targeted by miRNAs in adipocytes WP1992,0.6583029604661326,1.0441176470588236,0.4365351756469044,['TMSB4X'],0.9817794151779391,0,0,1
225,IL-7 signaling pathway WP205,0.6583029604661326,1.0441176470588236,0.4365351756469044,['BAD'],0.9817794151779391,0,0,1
226,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.6583029604661326,1.0441176470588236,0.4365351756469044,['SUPT4H1'],0.9817794151779391,0,0,1
227,Nicotine Activity on Dopaminergic Neurons WP1602,0.6583029604661326,1.0441176470588236,0.4365351756469044,['CDK5'],0.9817794151779391,0,0,1
228,Osteoclast Signaling WP12,0.6583029604661326,1.0441176470588236,0.4365351756469044,['ATP6V1G1'],0.9817794151779391,0,0,1
229,Physiological and pathological hypertrophy of the heart WP1528,0.6583029604661326,1.0441176470588236,0.4365351756469044,['CALM2'],0.9817794151779391,0,0,1
230,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.6583029604661326,1.0441176470588236,0.4365351756469044,['BAX'],0.9817794151779391,0,0,1
231,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6583029604661326,1.0441176470588236,0.4365351756469044,['HRAS'],0.9817794151779391,0,0,1
232,SARS-CoV-2 mitochondrial interactions WP5038,0.6583029604661326,1.0441176470588236,0.4365351756469044,['PHB'],0.9817794151779391,0,0,1
233,Oxidative Damage WP3941,0.6657452652558558,0.8945726762320648,0.3639552528652074,"['BAD', 'GADD45A', 'CYCS']",0.984392571703103,0,0,3
234,Prolactin Signaling Pathway WP2037,0.6657452652558558,0.8945726762320648,0.3639552528652074,"['RPS6', 'PPIB', 'HRAS']",0.984392571703103,0,0,3
235,DNA damage response (only ATM dependent) WP710,0.6754013221757948,0.8786885245901639,0.3448397416225307,"['BAD', 'RAC3', 'BAX', 'HRAS']",0.9928829191213118,0,0,4
236,Fragile X Syndrome  WP4549,0.7049855793300579,0.8347161572052402,0.2917983474001079,"['PRKAR1A', 'AP2S1', 'AP2M1']",0.9928829191213118,0,0,3
237,Head and Neck Squamous Cell Carcinoma WP4674,0.7056715602417788,0.8348964013086151,0.2910493620902558,"['RPS6', 'HRAS']",0.9928829191213118,0,0,2
238,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.7243842956096809,0.8350762527233115,0.26925633544708644,['HRAS'],0.9928829191213118,0,0,1
239,Biogenic Amine Synthesis WP550,0.7243842956096809,0.8350762527233115,0.26925633544708644,['GAD2'],0.9928829191213118,0,0,1
240,Bladder cancer WP2828,0.7243842956096809,0.8350762527233115,0.26925633544708644,['HRAS'],0.9928829191213118,0,0,1
241,Genes related to primary cilium development (based on CRISPR) WP4536,0.7243842956096809,0.8350762527233115,0.26925633544708644,['DYNLL1'],0.9928829191213118,0,0,1
242,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.7243842956096809,0.8350762527233115,0.26925633544708644,['SMO'],0.9928829191213118,0,0,1
243,MAPK Cascade WP422,0.7243842956096809,0.8350762527233115,0.26925633544708644,['HRAS'],0.9928829191213118,0,0,1
244,miRNA regulation of prostate cancer signaling pathways WP3981,0.7243842956096809,0.8350762527233115,0.26925633544708644,['BAD'],0.9928829191213118,0,0,1
245,Notch Signaling WP268,0.7243842956096809,0.8350762527233115,0.26925633544708644,['DLL3'],0.9928829191213118,0,0,1
246,Proximal tubule transport WP4917,0.7402919306946077,0.7945875618006766,0.23894095779693336,"['ATP6V1G1', 'ATP6V1E1', 'ATP6V1D', 'ATP6V1F']",0.9928829191213118,0,0,4
247,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.7479442977115165,0.758798453454942,0.22037538549672558,"['NPPA', 'CALM2']",0.9928829191213118,0,0,2
248,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7479442977115165,0.758798453454942,0.22037538549672558,"['IFI27L2', 'HRAS']",0.9928829191213118,0,0,2
249,Corticotropin-releasing hormone signaling pathway WP2355,0.7727053029538761,0.7361289493963524,0.18981640088109367,"['POMC', 'STAR', 'CRH']",0.9928829191213118,0,0,3
250,Folate Metabolism WP176,0.7727053029538761,0.7361289493963524,0.18981640088109367,"['AHCY', 'GPX4', 'SOD1']",0.9928829191213118,0,0,3
251,Alpha 6 Beta 4 signaling pathway WP244,0.7776972134932055,0.6957153231663036,0.1749153664582826,['HRAS'],0.9928829191213118,0,0,1
252,Apoptosis Modulation by HSP70 WP384,0.7776972134932055,0.6957153231663036,0.1749153664582826,['CYCS'],0.9928829191213118,0,0,1
253,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.7776972134932055,0.6957153231663036,0.1749153664582826,['CALM2'],0.9928829191213118,0,0,1
254,Target Of Rapamycin (TOR) Signaling WP1471,0.7776972134932055,0.6957153231663036,0.1749153664582826,['IDI1'],0.9928829191213118,0,0,1
255,Canonical and non-canonical Notch signaling WP3845,0.7776972134932055,0.6957153231663036,0.1749153664582826,['DLL3'],0.9928829191213118,0,0,1
256,Transcriptional cascade regulating adipogenesis WP4211,0.7776972134932055,0.6957153231663036,0.1749153664582826,['DDIT3'],0.9928829191213118,0,0,1
257,Urea cycle and metabolism of amino groups WP497,0.7776972134932055,0.6957153231663036,0.1749153664582826,['ODC1'],0.9928829191213118,0,0,1
258,Development of ureteric collection system WP5053,0.7776972134932055,0.6957153231663036,0.1749153664582826,['SMO'],0.9928829191213118,0,0,1
259,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.7776972134932055,0.6957153231663036,0.1749153664582826,['MAP1LC3A'],0.9928829191213118,0,0,1
260,Glutathione metabolism WP100,0.7776972134932055,0.6957153231663036,0.1749153664582826,['GPX4'],0.9928829191213118,0,0,1
261,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7776972134932055,0.6957153231663036,0.1749153664582826,['DDIT3'],0.9928829191213118,0,0,1
262,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7776972134932055,0.6957153231663036,0.1749153664582826,['BAX'],0.9928829191213118,0,0,1
263,Neovascularisation processes WP4331,0.7776972134932055,0.6957153231663036,0.1749153664582826,['KIT'],0.9928829191213118,0,0,1
264,Nuclear receptors WP170,0.7776972134932055,0.6957153231663036,0.1749153664582826,['NR2F6'],0.9928829191213118,0,0,1
265,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.7776972134932055,0.6957153231663036,0.1749153664582826,['LDHA'],0.9928829191213118,0,0,1
266,3q29 copy number variation syndrome WP4906,0.784887636213593,0.6953834969102145,0.16843211206128164,"['NCBP2', 'DYNLL1']",0.9928829191213118,0,0,2
267,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.784887636213593,0.6953834969102145,0.16843211206128164,"['BEX3', 'RNF7']",0.9928829191213118,0,0,2
268,22q11.2 copy number variation syndrome WP4657,0.7948396351929083,0.7251128534093609,0.1664967163495007,"['RANBP1', 'MRPL40', 'DGCR6L', 'RAN']",0.9928829191213118,0,0,4
269,Circadian rhythm related genes WP3594,0.7990553214740953,0.7809065934065934,0.17517694748732995,"['AHCY', 'STAR', 'CAVIN3', 'CRH', 'RPS27A', 'UBA52', 'SKP1', 'NR2F6', 'HCRTR1']",0.9928829191213118,0,0,9
270,Ectoderm Differentiation WP2858,0.8014815225273637,0.6950509461426492,0.15381015980853402,"['MAFB', 'ARHGDIG', 'LY6E']",0.9928829191213118,0,0,3
271,Hippo-Merlin Signaling Dysregulation WP4541,0.8014815225273637,0.6950509461426492,0.15381015980853402,"['PRKAR1A', 'KIT', 'HRAS']",0.9928829191213118,0,0,3
272,Pathogenic Escherichia coli infection WP2272,0.8014815225273637,0.6950509461426492,0.15381015980853402,"['YWHAQ', 'ARPC5L', 'ACTG1']",0.9928829191213118,0,0,3
273,Focal Adhesion WP306,0.814315017114264,0.7185165622877839,0.14758904207421913,"['BAD', 'RAC3', 'HRAS', 'MYL12B', 'ACTG1']",0.9928829191213118,0,0,5
274,Zinc homeostasis WP3529,0.8169807991836135,0.6417246875262143,0.12971802684112263,"['MT3', 'SLC39A3']",0.9928829191213118,0,0,2
275,Endochondral Ossification with Skeletal Dysplasias WP4808,0.8169807991836135,0.6417246875262143,0.12971802684112263,"['HMGCS1', 'CALM2']",0.9928829191213118,0,0,2
276,Endochondral Ossification WP474,0.8169807991836135,0.6417246875262143,0.12971802684112263,"['HMGCS1', 'CALM2']",0.9928829191213118,0,0,2
277,Oncostatin M Signaling Pathway WP2374,0.8169807991836135,0.6417246875262143,0.12971802684112263,"['RPS6', 'HRAS']",0.9928829191213118,0,0,2
278,Prader-Willi and Angelman Syndrome WP3998,0.8169807991836135,0.6417246875262143,0.12971802684112263,"['POMC', 'NDN']",0.9928829191213118,0,0,2
279,Pre-implantation embryo WP3527,0.8169807991836135,0.6417246875262143,0.12971802684112263,"['DDIT3', 'HMGA1']",0.9928829191213118,0,0,2
280,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.8207066903719513,0.596171802054155,0.11779728372040976,['PPIB'],0.9928829191213118,0,0,1
281,Interferon type I signaling pathways WP585,0.8207066903719513,0.596171802054155,0.11779728372040976,['RPS6'],0.9928829191213118,0,0,1
282,Joubert Syndrome WP4656,0.8207066903719513,0.596171802054155,0.11779728372040976,['ARL2'],0.9928829191213118,0,0,1
283,Pathways affected in adenoid cystic carcinoma WP3651,0.8207066903719513,0.596171802054155,0.11779728372040976,['HRAS'],0.9928829191213118,0,0,1
284,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8207066903719513,0.596171802054155,0.11779728372040976,['BAX'],0.9928829191213118,0,0,1
285,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8207066903719513,0.596171802054155,0.11779728372040976,['GSTP1'],0.9928829191213118,0,0,1
286,Prion disease pathway WP3995,0.8207066903719513,0.596171802054155,0.11779728372040976,['HSP90B1'],0.9928829191213118,0,0,1
287,Breast cancer pathway WP4262,0.8314865951478169,0.7140666562353309,0.13177393341120378,"['GADD45A', 'KIT', 'BAX', 'HRAS', 'SKP1', 'DLL3']",0.9999725225414026,0,0,6
288,G1 to S cell cycle control WP45,0.8447169038816708,0.5957314223399284,0.10053190123661514,"['CDKN2D', 'GADD45A']",0.9999725225414026,0,0,2
289,Apoptosis WP254,0.8498953276400603,0.6252183406113537,0.10168681201733237,"['BAD', 'CYCS', 'BAX']",0.9999725225414026,0,0,3
290,DNA Replication WP466,0.8554022517624522,0.5215141612200436,0.0814518813320879,['UBA52'],0.9999725225414026,0,0,1
291,IL-5 signaling pathway WP127,0.8554022517624522,0.5215141612200436,0.0814518813320879,['RPS6'],0.9999725225414026,0,0,1
292,Melatonin metabolism and effects WP3298,0.8554022517624522,0.5215141612200436,0.0814518813320879,['CALM2'],0.9999725225414026,0,0,1
293,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.8554022517624522,0.5215141612200436,0.0814518813320879,['YWHAQ'],0.9999725225414026,0,0,1
294,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8554022517624522,0.5215141612200436,0.0814518813320879,['BAX'],0.9999725225414026,0,0,1
295,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8589492036756778,0.6409415720891131,0.09745227731282978,"['STRAP', 'HRAS', 'MEF2D', 'DLL3']",0.9999725225414026,0,0,4
296,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8599342096842352,0.7297396406307297,0.11011726883968763,"['GNG10', 'GNG3', 'RAB14', 'BAD', 'CDC37', 'KIT', 'RPS6', 'PELO', 'HRAS', 'HSP90B1']",0.9999725225414026,0,0,10
297,B Cell Receptor Signaling Pathway WP23,0.8685797327981336,0.5558705925118139,0.07831988315508007,"['HRAS', 'MEF2D']",0.9999725225414026,0,0,2
298,Striated Muscle Contraction Pathway WP383,0.8833895974852244,0.4634471072379569,0.057462322724483296,['ACTG1'],0.9999725225414026,0,0,1
299,ATM Signaling Network in Development and Disease  WP3878,0.8833895974852244,0.4634471072379569,0.057462322724483296,['CDK5'],0.9999725225414026,0,0,1
300,ATM Signaling Pathway WP2516,0.8833895974852244,0.4634471072379569,0.057462322724483296,['GADD45A'],0.9999725225414026,0,0,1
301,Blood Clotting Cascade WP272,0.8833895974852244,0.4634471072379569,0.057462322724483296,['F8A1'],0.9999725225414026,0,0,1
302,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8833895974852244,0.4634471072379569,0.057462322724483296,['RPS6'],0.9999725225414026,0,0,1
303,Glioblastoma signaling pathways WP2261,0.8833895974852244,0.4634471072379569,0.057462322724483296,['HRAS'],0.9999725225414026,0,0,1
304,Chemokine signaling pathway WP3929,0.8876870098604622,0.5680825724493846,0.06767912198935656,"['GNG10', 'GNG3', 'HRAS']",0.9999725225414026,0,0,3
305,Endoderm differentiation WP2853,0.8890289459119789,0.5209923664122137,0.06128197921647376,"['TCEAL2', 'NME1']",0.9999725225414026,0,0,2
306,Retinoblastoma gene in cancer WP2446,0.8890289459119789,0.5209923664122137,0.06128197921647376,"['H2AFZ', 'STMN1']",0.9999725225414026,0,0,2
307,Ciliopathies WP4803,0.9031908343129212,0.5432409341180938,0.05531356017034957,"['SMO', 'NEK2', 'CCNQ']",0.9999725225414026,0,0,3
308,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9059645852988949,0.4169934640522876,0.041180215720175314,['HRAS'],0.9999725225414026,0,0,1
309,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9059645852988949,0.4169934640522876,0.041180215720175314,['ACTG1'],0.9999725225414026,0,0,1
310,White fat cell differentiation WP4149,0.9059645852988949,0.4169934640522876,0.041180215720175314,['DDIT3'],0.9999725225414026,0,0,1
311,Pregnane X receptor pathway WP2876,0.9059645852988949,0.4169934640522876,0.041180215720175314,['PSMC5'],0.9999725225414026,0,0,1
312,Prostaglandin Synthesis and Regulation WP98,0.9059645852988949,0.4169934640522876,0.041180215720175314,['S100A6'],0.9999725225414026,0,0,1
313,Pathways Regulating Hippo Signaling WP4540,0.9064913448092247,0.49021746103021363,0.048126509384560714,"['PRKAR1A', 'KIT']",0.9999725225414026,0,0,2
314,NRF2 pathway WP2884,0.9239103894237096,0.593960256610859,0.047006129453345556,"['FTH1', 'PRDX1', 'GSTP1', 'TXN', 'SLC39A3', 'FTL']",0.9999725225414026,0,0,6
315,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9241729665888979,0.3789859378094672,0.029885327080620472,['CALM2'],0.9999725225414026,0,0,1
316,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9241729665888979,0.3789859378094672,0.029885327080620472,['HRAS'],0.9999725225414026,0,0,1
317,TGF-beta Receptor Signaling WP560,0.9241729665888979,0.3789859378094672,0.029885327080620472,['HRAS'],0.9999725225414026,0,0,1
318,IL-4 signaling pathway WP395,0.9241729665888979,0.3789859378094672,0.029885327080620472,['BAD'],0.9999725225414026,0,0,1
319,Complement system WP2806,0.9296956495479479,0.5619788278431604,0.0409671353717672,"['FKBP2', 'RPS19', 'CD59', 'TXN', 'CALR']",0.9999725225414026,0,0,5
320,Metapathway biotransformation Phase I and II WP702,0.9296956495479479,0.5619788278431604,0.0409671353717672,"['GPX4', 'GSTO1', 'GSTP1', 'KCNAB1', 'SULT4A1']",0.9999725225414026,0,0,5
321,Osteoblast differentiation WP4787,0.9339747604237119,0.43838604143947657,0.029944337422234582,"['SMO', 'DLL3']",0.9999725225414026,0,0,2
322,Differentiation Pathway WP2848,0.9388586152937877,0.34731299927378356,0.02191210929510911,['KIT'],0.9999725225414026,0,0,1
323,T-cell receptor (TCR) signaling pathway WP69,0.9507024652244276,0.32051282051282054,0.016203246973753263,['HRAS'],0.9999725225414026,0,0,1
324,Vitamin A and carotenoid metabolism WP716,0.9507024652244276,0.32051282051282054,0.016203246973753263,['CRABP1'],0.9999725225414026,0,0,1
325,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9507024652244276,0.32051282051282054,0.016203246973753263,['STMN1'],0.9999725225414026,0,0,1
326,PI3K-Akt signaling pathway WP4172,0.957154887824286,0.5723153790832356,0.025061720993799674,"['GNG10', 'GNG3', 'BAD', 'CDC37', 'KIT', 'RPS6', 'HRAS', 'HSP90B1']",0.9999725225414026,0,0,8
327,Apoptosis Modulation and Signaling WP1772,0.9593562694148763,0.4750039032006245,0.019709228718312786,"['ENDOG', 'BAD', 'CYCS', 'BAX']",0.9999725225414026,0,0,4
328,Male infertility WP4673,0.9602539435919578,0.2975412387177093,0.012067530254908976,['HMGA1'],0.9999725225414026,0,0,1
329,Microglia Pathogen Phagocytosis Pathway WP3937,0.9602539435919578,0.2975412387177093,0.012067530254908976,['RAC3'],0.9999725225414026,0,0,1
330,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9602539435919578,0.2975412387177093,0.012067530254908976,['YWHAQ'],0.9999725225414026,0,0,1
331,Mesodermal commitment pathway WP2857,0.9676915939568663,0.36176568204447396,0.011881052005249687,"['PRKAR1A', 'RPL38']",0.9999725225414026,0,0,2
332,Neural Crest Differentiation WP2064,0.9679563461231474,0.2776325344952796,0.009042016814331299,['DLL3'],0.9999725225414026,0,0,1
333,Vitamin B12 metabolism WP1533,0.9741673201547919,0.2602124183006536,0.00681033236152291,['SOD1'],0.9999725225414026,0,0,1
334,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.9741673201547919,0.2602124183006536,0.00681033236152291,['NDUFA13'],0.9999725225414026,0,0,1
335,MECP2 and Associated Rett Syndrome WP3584,0.9791753980197642,0.24484172754068947,0.0051525698036790435,['RPS6'],0.9999725225414026,0,0,1
336,MAPK Signaling Pathway WP382,0.9794941410958101,0.4509561411854248,0.00934337072474856,"['GADD45A', 'DDIT3', 'STMN1', 'RAC3', 'HRAS']",0.9999725225414026,0,0,5
337,Ebola Virus Pathway on Host WP4217,0.9813456695629543,0.3197718312222129,0.006021468902137942,"['CLEC4G', 'ACTG1']",0.9999725225414026,0,0,2
338,ESC Pluripotency Pathways WP3931,0.9832133416468105,0.23117889130961025,0.003913662406618825,['HRAS'],0.9999725225414026,0,0,1
339,Wnt signaling pathway and pluripotency WP399,0.9912094615765413,0.19799771760556073,0.0017482016685768397,['PPM1J'],0.9999725225414026,0,0,1
340,Peptide GPCRs WP24,0.9929151284335908,0.1889483065953654,0.001343439171448266,['HCRTR1'],0.9999725225414026,0,0,1
341,Nuclear Receptors Meta-Pathway WP2882,0.993439287967308,0.4988260638040374,0.0032834368169300807,"['PSMC5', 'FTH1', 'CDC37', 'PRDX1', 'GSTP1', 'AIP', 'BAX', 'DBI', 'TXN', 'SLC39A3', 'FTL']",0.9999725225414026,0,0,11
342,Vitamin D Receptor Pathway WP2877,0.9972092445839751,0.31828499369482977,0.0008894973328570726,"['CDKN2D', 'GADD45A', 'PNOC', 'S100A6']",0.9999725225414026,0,0,4
343,"GPCRs, Other WP117",0.9975915359378367,0.15375615266682804,0.0003707628319525187,['SMO'],0.9999725225414026,0,0,1
344,Spinal Cord Injury WP2431,0.9982531670558684,0.26416891201337916,0.0004618624741607256,"['GADD45A', 'APEX1', 'MIF']",0.9999725225414026,0,0,3
345,Regulation of toll-like receptor signaling pathway WP1449,0.9993398653265947,0.12560242952399814,8.294189821719797e-05,['CUEDC2'],0.9999725225414026,0,0,1
346,"GPCRs, Class A Rhodopsin-like WP455",0.9999725225414026,0.17629444791016843,4.8441899467285905e-06,"['MAS1', 'GPR22', 'HCRTR1']",0.9999725225414026,0,0,3
